Aldapt, Mahmood, Yu-Hung Wang, Kashish J. Shah, Mobachir El Kettani, James Foran, Mohamed Kharfan-Dabaja, Hemant Murthy, Aref Al-Kali, Mithun V. Shah, Hassan Alkhateeb, Antoine N. Saliba, William Hogan, Cecilia Arana Yi, Lisa Sproat, Nathan Punwani, Nandita Khera, Jeanne Palmer, Mark Litzow, Ayalew Tefferi, Naseema Gangat, Mrinal M. Patnaik, and Talha Badar. 2020. “Clinical Outcomes of Venetoclax Combined With Hypomethylating Agents Versus Hypomethylating Agents Alone in <i>TP53</I&gt;-Mutated Myelodysplastic Syndromes”. Haematologica, September. Pavia, Italy. https://doi.org/10.3324/haematol.2025.289268.